Markus Hinder
Impact in
-
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Health Informatics top 10%
Papers in
-
- Cardiac electrophysiology and arrhythmias 4
- Atrial Fibrillation Management and Outcomes 4
- Heart Failure Treatment and Management 4
-
- Pharmaceutical Economics and Policy 9
- Innovation Policy and R&D 8
- Co-authors
- Alexander Schuhmacher (17 shared papers)Oliver Gassmann (16 shared papers)Dominik Hartl (9 shared papers)Thomas Langenickel (8 shared papers)Parasar Pal (5 shared papers)Michael Kuss (3 shared papers)Charlotte Wagner (3 shared papers)Bernhard K. Krämer (2 shared papers)
- Journals
- Drug Discovery Today (10 papers)The Journal of Clinical Pharmacology (4 papers)Journal of Translational Medicine (3 papers)Clinical Pharmacology & Therapeutics (3 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Markus Hinder
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 138
- Cardiology and Cardiovascular Medicine 279
- Health Informatics 16
- Management of Technology and Innovation 88
- Internal Medicine 31
- Endocrinology, Diabetes and Metabolism 111
Countries citing papers authored by Markus Hinder
This map shows the geographic impact of Markus Hinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hinder more than expected).
Fields of papers citing papers by Markus Hinder
This network shows the impact of papers produced by Markus Hinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hinder. The network helps show where Markus Hinder may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Hinder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 217 | |
| 2 | 2016 | 106 | |
| 3 | 2021 | 94 | |
| 4 | 2015 | 83 | |
| 5 | 2021 | 52 | |
| 6 | 2018 | 45 | |
| 7 | 2023 | 42 | |
| 8 | 2021 | 42 | |
| 9 | 2016 | 41 | |
| 10 | 2020 | 41 | |
| 11 | 2021 | 40 | |
| 12 | 1999 | 37 | |
| 13 | 1998 | 35 | |
| 14 | 2022 | 26 | |
| 15 | 2006 | 25 | |
| 16 | 2007 | 22 | |
| 17 | 2016 | 22 | |
| 18 | 2016 | 22 | |
| 19 | 2021 | 21 | |
| 20 | 2023 | 19 |
About Markus Hinder
Markus Hinder is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Molecular Biology, Public Health, Environmental and Occupational Health and Pharmacology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (9 papers), Innovation Policy and R&D (8 papers), Biotechnology and Related Fields (7 papers), Intellectual Property and Patents (4 papers), Cardiac electrophysiology and arrhythmias (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Heart Failure Treatment and Management (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (279 citations), Health Informatics (16 citations), Management of Technology and Innovation (88 citations), Internal Medicine (31 citations) and Endocrinology, Diabetes and Metabolism (111 citations). Markus Hinder has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Alexander Schuhmacher, Oliver Gassmann, Dominik Hartl, Thomas Langenickel, Parasar Pal, Michael Kuss, Charlotte Wagner, Bernhard K. Krämer, Surya Ayalasomayajula and Fan Yang. Their work appears in journals such as Drug Discovery Today, The Journal of Clinical Pharmacology, Journal of Translational Medicine, Clinical Pharmacology & Therapeutics and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.